442 related articles for article (PubMed ID: 28157718)
21. Interactions of U937 macrophage-like cells with decellularized pericardial matrix materials: influence of crosslinking treatment.
McDade JK; Brennan-Pierce EP; Ariganello MB; Labow RS; Michael Lee J
Acta Biomater; 2013 Jul; 9(7):7191-9. PubMed ID: 23454057
[TBL] [Abstract][Full Text] [Related]
22. Response of macrophage-like U937 cells to decellularized tissue heart valve materials.
Ariganello MB; Labow RS; Lee JM
J Heart Valve Dis; 2009 Mar; 18(2):187-97. PubMed ID: 19455894
[TBL] [Abstract][Full Text] [Related]
23. Pathologic findings in explanted clinical bioprosthetic valves fabricated from photooxidized bovine pericardium.
Schoen FJ
J Heart Valve Dis; 1998 Mar; 7(2):174-9. PubMed ID: 9587858
[TBL] [Abstract][Full Text] [Related]
24. In vivo efficacy of alpha-galactosidase as possible promise for prolonged durability of bioprosthetic heart valve using alpha1,3-galactosyltransferase knockout mouse.
Lim HG; Choi SY; Yoon EJ; Kim SH; Kim YJ
Tissue Eng Part A; 2013 Nov; 19(21-22):2339-48. PubMed ID: 23672462
[TBL] [Abstract][Full Text] [Related]
25. First quantification of alpha-Gal epitope in current glutaraldehyde-fixed heart valve bioprostheses.
Naso F; Gandaglia A; Bottio T; Tarzia V; Nottle MB; d'Apice AJ; Cowan PJ; Cozzi E; Galli C; Lagutina I; Lazzari G; Iop L; Spina M; Gerosa G
Xenotransplantation; 2013; 20(4):252-61. PubMed ID: 23865597
[TBL] [Abstract][Full Text] [Related]
26. Decellularized tissue-engineered heart valves calcification: what do animal and clinical studies tell us?
Badria AF; Koutsoukos PG; Mavrilas D
J Mater Sci Mater Med; 2020 Dec; 31(12):132. PubMed ID: 33278023
[TBL] [Abstract][Full Text] [Related]
27. Radical polymerization-crosslinking method for improving extracellular matrix stability in bioprosthetic heart valves with reduced potential for calcification and inflammatory response.
Guo G; Jin L; Jin W; Chen L; Lei Y; Wang Y
Acta Biomater; 2018 Dec; 82():44-55. PubMed ID: 30326277
[TBL] [Abstract][Full Text] [Related]
28. Biomaterial characterization of off-the-shelf decellularized porcine pericardial tissue for use in prosthetic valvular applications.
Choe JA; Jana S; Tefft BJ; Hennessy RS; Go J; Morse D; Lerman A; Young MD
J Tissue Eng Regen Med; 2018 Jul; 12(7):1608-1620. PubMed ID: 29749108
[TBL] [Abstract][Full Text] [Related]
29. Structural Model for Viscoelastic Properties of Pericardial Bioprosthetic Valves.
Rassoli A; Fatouraee N; Guidoin R
Artif Organs; 2018 Jun; 42(6):630-639. PubMed ID: 29602267
[TBL] [Abstract][Full Text] [Related]
30. Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization.
Schoen FJ; Tsao JW; Levy RJ
Am J Pathol; 1986 Apr; 123(1):134-45. PubMed ID: 2421577
[TBL] [Abstract][Full Text] [Related]
31. Decellularization and engineered crosslinking: a promising dual approach towards bioprosthetic heart valve longevity.
Human P; Ofoegbu C; Ilsley H; Bezuidenhout D; de Villiers J; Williams DF; Zilla P
Eur J Cardiothorac Surg; 2020 Dec; 58(6):1192-1200. PubMed ID: 32893300
[TBL] [Abstract][Full Text] [Related]
32. Anisotropic elasticity and strength of glutaraldehyde fixed bovine pericardium for use in pericardial bioprosthetic valves.
Zioupos P; Barbenel JC; Fisher J
J Biomed Mater Res; 1994 Jan; 28(1):49-57. PubMed ID: 8126028
[TBL] [Abstract][Full Text] [Related]
33. Prevention of calcification with TPEN in pericardial bioprosthetic heart valve material.
Döndaş HA; Yilmaz N; Cömelekoğlu U; Tamer L; Sucu N; Aytaçoğlu BN; Ozeren M; Köse N; Dikmengil M
Anadolu Kardiyol Derg; 2007 Dec; 7(4):365-70. PubMed ID: 18065330
[TBL] [Abstract][Full Text] [Related]
34. A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium.
Neethling WM; Hodge AJ; Clode P; Glancy R
J Cardiovasc Surg (Torino); 2006 Dec; 47(6):711-8. PubMed ID: 17043620
[TBL] [Abstract][Full Text] [Related]
35. Decellularized and photooxidatively crosslinked bovine jugular veins as potential tissue engineering scaffolds.
Lü WD; Zhang M; Wu ZS; Hu TH
Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):301-5. PubMed ID: 19074454
[TBL] [Abstract][Full Text] [Related]
36. Complete Static Repopulation of Decellularized Porcine Tissues for Heart Valve Engineering: An in vitro Study.
Roosens A; Asadian M; De Geyter N; Somers P; Cornelissen R
Cells Tissues Organs; 2017; 204(5-6):270-282. PubMed ID: 29131080
[TBL] [Abstract][Full Text] [Related]
37. A universal strategy for the construction of polymer brush hybrid non-glutaraldehyde heart valves with robust anti-biological contamination performance and improved endothelialization potential.
Yu T; Zheng C; Chen X; Pu H; Li G; Jiang Q; Wang Y; Guo Y
Acta Biomater; 2023 Apr; 160():87-97. PubMed ID: 36812953
[TBL] [Abstract][Full Text] [Related]
38. Preseeding of human vascular cells in decellularized bovine pericardium scaffold for tissue-engineered heart valve: an in vitro and in vivo feasibility study.
Yang M; Chen CZ; Shu YS; Shi WP; Cheng SF; Gu YJ
J Biomed Mater Res B Appl Biomater; 2012 Aug; 100(6):1654-61. PubMed ID: 22707089
[TBL] [Abstract][Full Text] [Related]
39. Mapping of glutaraldehyde-treated bovine pericardium and tissue selection for bioprosthetic heart valves.
Simionescu D; Simionescu A; Deac R
J Biomed Mater Res; 1993 Jun; 27(6):697-704. PubMed ID: 8408100
[TBL] [Abstract][Full Text] [Related]
40. Advantages of decellularized bovine pericardial scaffolds compared to glutaraldehyde fixed bovine pericardial patches demonstrated in a 180-day implant ovine study.
Botes L; Laker L; Dohmen PM; van den Heever JJ; Jordaan CJ; Lewies A; Smit FE
Cell Tissue Bank; 2022 Dec; 23(4):791-805. PubMed ID: 35037183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
